Report Company Directory

Aslan Pharmaceuticals ADS

• ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation by GlobeNewsWire
• ASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to Appeal by GlobeNewsWire
• ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change by GlobeNewsWire
• ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference by GlobeNewsWire
• ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update by GlobeNewsWire
• ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event by GlobeNewsWire
• ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics by GlobeNewsWire
• ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab by GlobeNewsWire
• ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference by GlobeNewsWire
• ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients by GlobeNewsWire

ASM AUTOMATION GROUP BERHAD

ASM Group SA

• Ford Equity International Rating and Forecast Report by Ford Equity Research

ASM International N.V.

• HOLT Europe "Stock Highlights from the Week - 25th July 2025" Azevedo by UBS AG
• ASM announces completion of share buyback program by GlobeNewsWire
• Samsung Electronics "Discloses Won22.8tn foundry order - initial take" (Neutral) by UBS AG
• EU-US Tariff Deal + Samsung/TSLA 2nm Deal by BNP Paribas Exane
• Intel 2Q Earnings - ASML/ASM Read-x by BNP Paribas Exane
• Analyse Technique - ASM INTERNATIONAL - Liste recommandée : clôture by CIC Market Solutions
• ASM International "Moving on to a more positive CMD catalyst. Buy." (Buy) by UBS AG
• ASM International NV (ASM NA) by HSBC
• Bringing down expectations by BNP Paribas Exane
• Conference call feedback by BNP Paribas Exane

ASM International N.V.

• EU-US Tariff Deal + Samsung/TSLA 2nm Deal by BNP Paribas Exane
• Intel 2Q Earnings - ASML/ASM Read-x by BNP Paribas Exane
• Bringing down expectations by BNP Paribas Exane
• Conference call feedback by BNP Paribas Exane
• Q2 25 results - weak orders and guidance by BNP Paribas Exane
• TSMC Earnings Call - ASML/ASM Read-x by BNP Paribas Exane
• EU Semi readacross from Asian SPE initiations by BNP Paribas Exane
• Q2 25 preview: Mixed fortunes by BNP Paribas Exane
• US planning to impose restrictions on Taiwan/Korea-owned fabs in China - European read-x by BNP Paribas Exane
• Expert Access Feedback - What’s happening at ASMI? by BNP Paribas Exane